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Mammalian cells generate citrate by decarboxylating
pyruvate in the mitochondria to supply the tricar-
boxylic acid (TCA) cycle. In contrast, hypoxia and
other impairments of mitochondrial function induce
an alternative pathway that produces citrate by
reductively carboxylating a-ketoglutarate (AKG) via
NADPH-dependent isocitrate dehydrogenase (IDH).
It is unknown how cells generate reducing equiva-
lents necessary to supply reductive carboxylation
in the setting of mitochondrial impairment. Here,
we identified shared metabolic features in cells using
reductive carboxylation. Paradoxically, reductive
carboxylation was accompanied by concomitant
AKG oxidation in the TCA cycle. Inhibiting AKG
oxidation decreased reducing equivalent availability
and suppressed reductive carboxylation. Interrupt-
ing transfer of reducing equivalents from NADH to
NADPH by nicotinamide nucleotide transhydroge-
nase increased NADH abundance and decreased
NADPH abundance while suppressing reductive
carboxylation. The data demonstrate that reductive
carboxylation requires bidirectional AKGmetabolism
along oxidative and reductive pathways, with the
oxidative pathway producing reducing equivalents
used to operate IDH in reverse.INTRODUCTION
Proliferating cells support their growth by converting abundant
extracellular nutrients like glucose and glutamine into precursorsCfor macromolecular biosynthesis. A continuous supply of meta-
bolic intermediates from the tricarboxylic acid (TCA) cycle is
essential for cell growth, because many of these intermediates
feed biosynthetic pathways to produce lipids, proteins, and
nucleic acids (Deberardinis et al., 2008). This underscores the
dual roles of the TCA cycle for cell growth: it generates reducing
equivalents for oxidative phosphorylation by the electron trans-
port chain (ETC) while also serving as a hub for precursor pro-
duction. During rapid growth, the TCA cycle is characterized
by large influxes of carbon at positions other than acetyl-coen-
zyme A (acetyl-CoA), enabling the cycle to remain full even as
intermediates are withdrawn for biosynthesis. Cultured cancer
cells usually display persistence of TCA cycle activity despite
robust aerobic glycolysis and often require mitochondrial catab-
olism of glutamine to the TCA cycle intermediate a-ketoglutarate
(AKG) to maintain rapid rates of proliferation (Icard et al., 2012;
Hiller and Metallo, 2013).
Some cancer cells contain severe, fixed defects in oxidative
metabolism caused by mutations in the TCA cycle or the ETC.
These include mutations in fumarate hydratase (FH) in renal
cell carcinoma and components of the succinate dehydroge-
nase (SDH) complex in pheochromocytoma, paraganglioma,
and gastrointestinal stromal tumors (Tomlinson et al., 2002;
Astuti et al., 2001; Baysal et al., 2000; Killian et al., 2013; Nie-
mann and Mu¨ller, 2000). All of these mutations alter oxidative
metabolism of glutamine in the TCA cycle. Recently, analysis
of cells containing mutations in FH or ETC complexes I or III or
exposed to the ETC inhibitors metformin and rotenone or the
ATP synthase inhibitor oligomycin revealed that turnover of
TCA cycle intermediates was maintained in all cases (Mullen
et al., 2012). However, the cycle operated in an unusual fashion
characterized by conversion of glutamine-derived AKG to isoci-
trate through a reductive carboxylation reaction catalyzed by
NADP+/NADPH-dependent isoforms of isocitrate dehydroge-
nase (IDH). As a result, a large fraction of the citrate pool carriedell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authors 1679
five glutamine-derived carbons. Citrate could be cleaved to pro-
duce acetyl-CoA to supply fatty acid biosynthesis and oxaloac-
etate (OAA) to supply pools of other TCA cycle intermediates.
Thus, reductive carboxylation enables biosynthesis by enabling
cells with impaired mitochondrial metabolism to maintain pools
of biosynthetic precursors that would normally be supplied by
oxidative metabolism. Reductive carboxylation is also induced
by hypoxia and by pseudohypoxic states caused by mutations
in the von Hippel-Lindau (VHL) tumor-suppressor gene (Metallo
et al., 2012; Wise et al., 2011).
Interest in reductive carboxylation stems in part from the pos-
sibility that inhibiting the pathway might induce selective growth
suppression in tumor cells subjected to hypoxia or containing
mutations that prevent them from engaging in maximal oxidative
metabolism. Hence, several recent studies have sought to un-
derstand the mechanisms by which this pathway operates.
In vitro studies of IDH1 indicate that a high ratio of NADPH/
NADP+ and low citrate concentration activate the reductive
carboxylation reaction (Leonardi et al., 2012). This is supported
by data demonstrating that reductive carboxylation in VHL-defi-
cient renal carcinoma cells is associated with a low concentra-
tion of citrate and a reduced ratio of citrate:AKG, suggesting
that mass action can be a driving force to determine IDH direc-
tionality (Gameiro et al., 2013b). Moreover, interrupting the
supply of mitochondrial NADPH by silencing nicotinamide nucle-
otide transhydrogenase (NNT) suppresses reductive carboxyla-
tion (Gameiro et al., 2013a). This mitochondrial transmembrane
protein catalyzes the transfer of a hydride ion from NADH to
NADP+ to generate NAD+ and NADPH. Together, these observa-
tions suggest that reductive carboxylation is modulated in part
through the mitochondrial redox state and the balance of sub-
strate/products.
Here, we used metabolomics and stable isotope tracing to
better understand overall metabolic states associated with
reductive carboxylation in cells with defective mitochondrial
metabolism and to identify sources of mitochondrial reducing
equivalents necessary to induce the reaction. We identified
high levels of succinate in some cells using reductive carboxyla-
tion and determined that most of this succinate was formed
through persistent oxidative metabolism of AKG. Silencing this
oxidative flux by depleting the mitochondrial enzyme AKG dehy-
drogenase substantially altered the cellular redox state and
suppressed reductive carboxylation. The data demonstrate
that bidirectional/branched AKG metabolism occurs during
reductive carboxylation in cells with mitochondrial defects,
with oxidative metabolism producing reducing equivalents to
supply reductive metabolism.
RESULTS
Shared Metabolomic Features among Cell Lines with
cytb or FH Mutations
To identify conserved metabolic features associated with
reductive carboxylation in cells harboring defective mitochon-
drial metabolism, we analyzed metabolite abundance in
isogenic pairs of cell lines in which one member displayed
substantial reductive carboxylation and the other did not.
We used a pair of previously described cybrids derived from1680 Cell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authors143B osteosarcoma cells in which one cell line contained
wild-type mitochondrial DNA (143Bwt) and the other contained
a mutation in the cytb gene (143Bcytb), severely reducing
complex III function (Rana et al., 2000; Weinberg et al., 2010).
The 143Bwt cells primarily use oxidative metabolism to
supply the citrate pool, while the 143Bcytb cells use reductive
carboxylation (Mullen et al., 2012). The other pair, derived from
FH-deficient UOK262 renal carcinoma cells, contained either
an empty vector control (UOK262EV) or a stably re-expressed
wild-type FH allele (UOK262FH). Metabolites were extracted
from all four cell lines and analyzed by triple-quadrupole
mass spectrometry. We first performed a quantitative analysis
to determine the abundance of AKG and citrate in the four
cell lines. Both 143Bcytb and UOK262EV cells had less
citrate, more AKG, and lower citrate:AKG ratios than their
oxidative partners (Figures S1A–S1C), consistent with findings
from VHL-deficient renal carcinoma cells (Gameiro et al.,
2013b).
Next, to identify other perturbations, we profiled the relative
abundance of more than 90 metabolites from glycolysis, the
pentose phosphate pathway, one-carbon/nucleotide meta-
bolism, the TCA cycle, amino acid degradation, and other path-
ways (Tables S1 and S2). Each metabolite was normalized to
protein content, and relative abundance was determined be-
tween cell lines fromeach pair. Hierarchical clustering (Figure 1A)
and principal component analysis (Figure 1B) revealed far
greater metabolomic similarities between the members of each
pair than between the two cell lines using reductive carboxyla-
tion. Only three metabolites displayed highly significant (p <
0.005) differences in abundance between the two members of
both pairs, and in all three cases, the direction of the difference
(i.e., higher or lower) was shared in the two cell lines using reduc-
tive carboxylation. Proline, a nonessential amino acid derived
from glutamine in an NADPH-dependent biosynthetic pathway,
was depleted in 143Bcytb and UOK262EV cells (Figure 1C).
2-hydroxyglutarate (2HG), the reduced form of AKG, was
elevated in 143Bcytb and UOK262EV cells (Figure 1D), and
further analysis revealed that while both the L- and D- enantio-
mers of this metabolite were increased, L-2HG was quantita-
tively the predominant enantiomer (Figure S1D). It is likely that
2HG accumulation was related to the reduced redox ratio asso-
ciated with cytb and FHmutations. Although the sources of 2HG
are still under investigation, promiscuous activity of the TCA
cycle enzyme malate dehydrogenase produces L-2HG in an
NADH-dependent manner (Rzem et al., 2007). Both enantiomers
are oxidized to AKG by dehydrogenases (L-2HG dehydrogenase
and D-2HG dehydrogenase). It is therefore likely that elevated
2-HG is a consequence of a reduced NAD+/NADH ratio. Consis-
tent with thismodel, inborn errors of the ETC result in 2-HG accu-
mulation (Reinecke et al., 2012). Exposure to hypoxia (<1% O2)
has also been demonstrated to reduce the cellular NAD+/
NADH ratio (Santidrian et al., 2013) and to favor modest 2HG
accumulation in cultured cells (Wise et al., 2011), although these
levels were below those noted in gliomas expressing 2HG-pro-
ducing mutant alleles of isocitrate dehydrogenase 1 or 2 (Dang
et al., 2009).
Finally, the TCA cycle intermediate succinate was markedly
elevated in both cell lines (Figure 1E). We tested additional
Figure 1. Metabolomic Features of Cells Using Reductive Carboxylation
(A) Relative abundance of metabolites extracted from triplicate samples of 143Bwt, 143Bcytb, UOK262FH, and UOK262EV cells. Peak areas of each metabolite
were normalized to protein abundance. The color reflects a log2 scale.
(B) Principal component analysis for the 12 extracts used to generate the heatmap in (A).
(C–E) Metabolites demonstrating consistent and significant alterations in abundance in cells using reductive carboxylation. In all cases, p < 0.005 for the
comparison between cells lines in each pair.
(F) Abundance of succinate in several models of reductive carboxylation induced by impaired ETC activity. High doses of metformin and rotenone inhibit
complex I. Antimycin inhibits complex III. Hypoxia functions as an inhibitor of complex IV. These treatments were all applied to 143Bwt cells. CCL16-B2 are
Chinese hamster fibroblast cells with impaired complex I activity as a consequence of NDUFA1mutation. CCL16-NDI1 cells were generated by stably infecting
CCL16-B2 with yeast NADH quinone oxidoreductase (NDI1), which restores oxidative capacity and eliminates reductive carboxylation. Data are the average and
SD of three independent cultures. *p < 0.05; **p < 0.005 (Student’s t test). NS, not significant.factors previously reported to stimulate reductive AKG meta-
bolism, including a genetic defect in ETC complex I, exposure
to hypoxia, and chemical inhibitors of the ETC (Mullen et al.,C2012; Wise et al., 2011; Metallo et al., 2012). These factors
had a variable effect on succinate, with impairments of com-
plex III or IV strongly inducing succinate accumulation, whileell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authors 1681
Figure 2. Oxidative Glutamine Metabolism
Is thePrimaryRoute of Succinate Formation
in Cells Using Reductive Carboxylation to
Generate Citrate
(A–C) 143Bwt cells were cultured in medium con-
taining unlabeled glucose and [U-13C]glutamine,
and labeling patterns in succinate, fumarate, and
malate were followed. Isotopologues with four 13C
atoms (m+4) are formed through oxidative meta-
bolism (green), and isotopologues with three 13C
atoms (m+3) are formed through reductive meta-
bolism (red). See Figure S2 for the labeling
scheme.
(D–F) 143Bcytb cells were cultured in medium
containingunlabeledglucoseand [U-13C]glutamine,
and labeling patterns in succinate, fumarate, and
malate were followed as in (A)–(C). Note that
succinate formation is primarily oxidative but that
fumarate and malate formation is almost exclu-
sively reductive, indicating bidirectionalmetabolism
of glutamine.impairments of complex I either had little effect or suppressed
succinate (Figure 1F).
Oxidative Glutamine Metabolism Is the Primary Route of
Succinate Formation
UOK262EV cells lack FH activity and accumulate large amounts
of fumarate (Frezza et al., 2011); elevated succinate was there-
fore not surprising in these cells, because succinate precedes
fumarate by one reaction in the TCA cycle. On the other hand,
TCA cycle perturbation in 143Bcytb cells results from primary
ETC dysfunction, and reductive carboxylation is postulated to
be a consequence of accumulated AKG (Anastasiou and Cant-
ley, 2012; Fendt et al., 2013). Accumulation of AKG is not pre-
dicted to result in elevated succinate. We previously reported
that 143Bcytb cells produce succinate through simultaneous
oxidative and reductive glutamine metabolism (Mullen et al.,
2012). To determine the relative contributions of these two path-
ways, we cultured 143Bwt and 143Bcytb with [U-13C]glutamine
and monitored time-dependent 13C incorporation in succinate
and other TCA cycle intermediates. Oxidative metabolism of
glutamine generates succinate, fumarate, andmalate containing
four glutamine-derived 13C nuclei on the first turn of the cycle
(m + 4), while reductive metabolism results in the incorporation
of three 13C nuclei in these intermediates (Figure S2). As ex-
pected, oxidative glutamine metabolism was the predominant
source of succinate, fumarate, and malate in 143Bwt cells (Fig-
ures 2A–2C). In 143Bcytb, fumarate and malate were produced
primarily through reductive metabolism (Figures 2E and 2F).
Conversely, succinate was formed primarily through oxidative
glutamine metabolism, with a minor contribution from the reduc-
tive carboxylation pathway (Figure 2D). Notably, this oxidatively
derived succinate was detected prior to that formed through
reductive carboxylation. This indicated that 143Bcytb cells retain1682 Cell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authorsthe ability to oxidize AKG despite the
observation that most of the citrate pool
bears the labeling pattern of reductive
carboxylation. Together, the labelingdata in 143Bcytb cells revealed bidirectional metabolism of car-
bon from glutamine to produce various TCA cycle intermediates.
Pyruvate Carboxylation Contributes to the TCA Cycle in
Cells Using Reductive Carboxylation
Because of the persistence of oxidative metabolism, we deter-
mined the extent to which other routes of metabolism besides
reductive carboxylation contributed to the TCA cycle. We previ-
ously reported that silencing the glutamine-catabolizing enzyme
glutaminase (GLS) depletes pools of fumarate, malate, and OAA,
eliciting a compensatory increase in pyruvate carboxylase (PC)
to supply the TCA cycle (Cheng et al., 2011). In cells with defec-
tive oxidative phosphorylation, production of OAA by PCmay be
preferable to glutamine oxidation because it diminishes the need
to recycle reduced electron carriers generated by the TCA cycle.
Citrate synthase (CS) can then condense PC-derived OAA with
acetyl-CoA to form citrate. To examine the contribution of PC
to the TCA cycle, cells were cultured with [3,4-13C]glucose. In
this labeling scheme, glucose-derived pyruvate is labeled in car-
bon 1 (Figure S3). This label is retained in OAA if pyruvate is
carboxylated but removed as CO2 during conversion of pyruvate
to acetyl-CoA by pyruvate dehydrogenase. Thus, labeling of TCA
cycle intermediates from [3,4-13C]glucose indicates activity of
PC. Both cell lines contained label in citrate and other TCA cycle
intermediates from [3,4-13C]glucose, but the fractional contribu-
tionwas significantly greater in 143Bcytb (Figure 3A). UOK262EV
cells also displayed PC-mediated labeling of TCA cycle interme-
diates, particularly malate; citrate labeling was barely above
baseline in both these cell lines (Figure 3B). Malate labeling
from PC was suppressed in UOK262FH cells because FH-
dependent production of fumarate, malate and OAA diluted the
PC-dependent labeling. Silencing PC expression in 143Bcytb
cells reduced PC-dependent transfer of carbon from glucose
Figure 3. Pyruvate Carboxylase Contrib-
utes to Citrate Formation in Cells Using
Reductive Carboxylation
(A and B) 143B and UOK262 cells were cultured
with [3,4-13C]glucose and unlabeled glutamine
and labeling patterns in malate and citrate were
analyzed. Data are the average and SD of three
independent cultures. *p < 0.05; **p < 0.005
(Student’s t test).
(C) Left: abundance of pyruvate carboxylase (PC)
protein in 143Bcytb cells stably expressing non-
targeting (shGFP) or two independent hairpins
targeting PC (shPC_1, shPC_2). Cells were
cultured with [3,4-13C]glucose and unlabeled
glutamine (middle) or with unlabeled glucose and
[U-13C]glutamine, and labeling patterns were
analyzed. Data are the average and SD of three
independent cultures. *p < 0.05; **p < 0.005
(Student’s t test).to the TCA cycle and increased the contribution of reductive
glutamine metabolism to the citrate pool (Figure 3C). Together,
the data demonstrate that PC-dependent oxidative glucose
metabolism contributes to the TCA cycle in these models of
glutamine-dependent reductive carboxylation.
Oxidative Metabolism of AKG Is Required for Reductive
Carboxylation
Oxidative synthesis of succinate from AKG requires two reac-
tions: the oxidative decarboxylation of AKG to succinyl-CoA by
AKG dehydrogenase and the conversion of succinyl coenzyme
A (succinyl-CoA) to succinate by succinyl-CoA synthetase. In
tumors with mutations in the SDH complex, large accumulationsCell Reports 7, 1679–169of succinate are associated with epige-
netic modifications of DNA and histones
to promote malignancy (Kaelin and
McKnight, 2013; Killian et al., 2013).
We therefore tested whether succinate
accumulation per se was required to in-
duce reductive carboxylation in 143Bcytb
cells. We used RNAi directed against
the gene encoding the alpha subunit
(SUCLG1) of succinyl-CoA synthetase,
the last step in the pathway of oxidative
succinate formation from glutamine (Fig-
ure 4A). Silencing this enzyme greatly
reduced succinate levels (Figure 4B) but
had no effect on the labeling pattern of
citrate from [U-13C]glutamine (Figure 4C).
Thus, succinate accumulation is not
required for reductive carboxylation.
We next tested whether the proximal
step in the oxidative pathway was
required for reductive carboxylation. In
143Bcytb cells, we transiently silenced
expression of the E1 component of the
AKG dehydrogenase complex encoded
by OGDH (Figure 5A). OGDH silencinggreatly diminished succinate abundance, validating effective
suppression of the pathway (Figure 5B). Surprisingly, both the
abundance of citrate and the fraction that contained five gluta-
mine-derived carbons from [U-13C]glutamine were suppressed
whenOGDHwas silenced, indicating a suppression of reductive
citrate formation (Figure 5C). Stable silencing of OGDH with
either of two small hairpin RNAs (shRNAs) produced a similar
metabolic effect (Figures S4A–S4C), as did transient OGDH
silencing in UOK262EV cells (Figures S4E and S4F). This was un-
expected given the association of a low citrate/AKG ratio with in-
duction of reductive carboxylation via mass action. To test
whether altering the citrate/AKG ratio by manipulating AKG de-
hydrogenase activity could stimulate reductive carboxylation in0, June 12, 2014 ª2014 The Authors 1683
Figure 4. Elevated Succinate Abundance Is
Dispensable for Reductive Carboxylation
(A) Abundance of the alpha subunit of succinate-
CoA ligase (encoded by SUCLG1) in 143Bcytb
cells transfected with a control siRNA (siLUC) or
siRNA directed against SUCLG1 (siSUCLG1).
(B) Relative abundance of succinate in 143Bcytb
following transient knockdown of LUC or
SUCLG1. Data are the average and SD of three
independent cultures. *p < 0.05 (Student’s t test).
(C) Fraction of citrate containing five glutamine-
derived 13C nuclei (m+5) following transient
knockdown of LUC or SUCLG1 and culture with
[U-13C]glutamine and unlabeled glucose. Data are
the average and SD of three independent cultures.
NS, not significant.cells with normal ETC function, OGDH was silenced in 143Bwt
cells (Figure 5D). Knockdown of OGDH significantly lowered
the citrate/AKG ratio to levels previously reported to induce
reductive carboxylation (Figure 5E) (Fendt et al., 2013; Gameiro
et al., 2013a). However, culture with [U-13C]glutamine revealed
a suppression of citrate formed through oxidative metabolism
(m + 4) and an increase in unlabeled citrate (m+0) but no
evidence for an increase in reductive carboxylation (m + 5;
Figure 5F). Together, the data demonstrate that a reduced
citrate:AKG ratio is not sufficient to induce reductive carboxyla-
tion in the absence of AKG dehydrogenase function and imply
that additional factors account for the role of AKG dehydroge-
nase in reductive carboxylation. To determine whether AKG
dehydrogenase suppression impaired growth of 143Bcytb cells,
OGDH was stably silenced and cells were challenged to form
colonies in soft agar. Over the 2-week assay, OGDH-depleted
cells formed colonies as effectively as control cells (Figure S4D).
Thus, the level of AKG dehydrogenase suppression achievable
through stable RNAi against OGDH was not sufficient to reduce
cell growth in this model.
As a further examination of the role of mitochondrial dysfunc-
tion in reductive carboxylation, we transfected UOK262EV cells
with an allele of FH that lacked a mitochondrial targeting
sequence and was confined to the cytosol (FHDMTS). This
form of FH was previously shown to reduce fumarate levels
and reverse some of the effects of FH deficiency inmurine kidney
cells (O’Flaherty et al., 2010). Transient expression of FHDMTS in
UOK262EV cells reduced fumarate abundance but had no effect
on the fraction of citrate formed through reductive carboxylation
(Figures 5G–5I).
AKG Dehydrogenase and NNT Maintain a Redox State
Favorable for Reductive Carboxylation
In addition to converting AKG to succinyl-CoA, AKG dehydroge-
nase also generates reducing equivalents as NADH. We there-
fore tested whether AKG dehydrogenase supported reductive
carboxylation by contributing to a low NAD+/NADH ratio. Two-
photon fluorescencemicroscopy revealed enhanced abundance
of NADH in the mitochondria of 143Bcytb cells compared to
143Bwt cells (Figure 6A). Enzymatic assays performed on
whole-cell lysates also demonstrated a reduced total NAD+/
NADH ratio in 143Bcytb cells (Figure 6B). Silencing OGDH re-1684 Cell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authorssulted in an increase in the NAD+/NADH ratio, indicating that
AKG dehydrogenase contributes to the low NAD+/NADH ratio
in 143Bcytb cells (Figure 6C). Importantly, NADPH rather than
NADH is the immediate source of reducing equivalents for the
reductive carboxylation reaction. Mitochondrial NADPH can be
produced fromNADH by the enzyme NNT, and this enzyme con-
tributes to reductive glutamine metabolism in some cancer cells
(Sazanov and Jackson, 1994; Gameiro et al., 2013a). We there-
fore tested the impact of silencing NNT on redox balance and
reductive carboxylation. Transfection with small interfering
RNAs (siRNAs) directed against NNT reduced abundance of the
transcript bymore than 80% and substantially reduced NNT pro-
tein levels (Figures S5A and S5B). This resulted in a reduction of
theNAD+/NADH ratio thatwas similar in size to the increasenoted
upon OGDH silencing (Figure 6D). Culture of these cells with
[U-13C]glutamine revealed a significant suppression of reductive
citrate formation compared to cells transfected with control
siRNA (Figure 6E). Transient NNT silencing also reduced reduc-
tive citrate formation in UOK262EV cells (Figures S5C and S5D).
Finally, we tested whether these enzymes also controlled the
NADP+/NADPH ratio in 143Bcytb cells. Silencing either OGDH
or NNT increased the NADP+/NADPH ratio (Figures 6F and
6G), whereas silencing IDH2 reduced it (Figure 6H). Together,
these data are consistent with a model in which persistent meta-
bolism of AKG by AKG dehydrogenase produces NADH that
supports reductive carboxylation by serving as substrate for
NNT-dependent NADPH formation and in which IDH2 is a major
consumer of NADPH during reductive carboxylation (Figure 6I).
DISCUSSION
Reductive carboxylation of AKG initiates a nonconventional
form of metabolism that produces TCA cycle intermediates
when oxidative metabolism is impaired by mutations, drugs, or
hypoxia. Because NADPH-dependent isoforms of IDH are
reversible, supplying supraphysiological pools of substrates on
either side of the reaction drives function of the enzyme as a
reductive carboxylase or an oxidative decarboxylase. Thus, in
some circumstances, reductive carboxylation may operate
in response to a mass effect imposed by drastic changes in
the abundance of AKG and isocitrate/citrate. However, reduc-
tive carboxylation cannot occur without a source of reducing
Figure 5. AKG Dehydrogenase Is Required
for Reductive Carboxylation
(A) Abundance of OGDH protein in 143Bcytb cells
transfected with a control siRNA (siLUC) or siRNA
directed against OGDH (siOGDH).
(B) Relative abundance of succinate in 143Bcytb
cells following transient knockdown of siLUC
or siOGDH. Data are the average and SD of
three independent cultures. **p < 0.005 (Student’s
t test).
(C) Abundance of m + 5-labeled citrate in
143Bcytb cells after transient knockdown of LUC
or OGDH cultured with [U-13C]glutamine and un-
labeled glucose. Abundance of labeled citrate was
calculated by multiplying the relative citrate pool
size by the percent citrate m + 5. Data are the
average and SD of three independent cultures.
*p < 0.05 (Student’s t test).
(D) Abundance of OGDH protein in 143Bwt cells
transiently transfected with LUC or OGDH.
(E) Ratio of citrate to AKG in 143Bwt cells following
knockdown of LUC or OGDH. Data are the
average and SD of four independent cultures. **p <
0.005 (Student’s t test).
(F) Mass isotopomer distribution of citrate in
143Bwt cells following transient knockdown of
LUC or OGDH and cultured with [U-13C]glutamine
and unlabeled glucose. Data are the average and
SD of three independent cultures. **p < 0.005,
Student’s t test.
(G) Western blot demonstrating expression of
fumarate hydratase lacking its mitochondrial
targeting sequence and containing a V5 epi-
tope tag (FHDMTS) in UOK262 cells. EV, empty
vector.
(H) Relative fumarate abundance in UOK262 cells
containing or lacking FHDMTS. Data are the
average and SD of three independent cultures.
*p < 0.05 (Student’s t test).
(I) Mass isotopomer distribution of citrate in
UOK262 cells containing or lacking FHDMTS.
Data are the average and SD of three independent
cultures. NS, not significant.equivalents to produce NADPH. The current work demonstrates
that AKG dehydrogenase, an NADH-generating enzyme com-
plex, is required tomaintain a lowNAD+/NADH ratio for reductive
carboxylation of AKG. Thus, reductive carboxylation not only
coexists with oxidative metabolism of AKG but also depends
on it. Furthermore, silencing NNT, a consumer of NADH, also
perturbs the redox ratio and suppresses reductive formation of
citrate. These observations suggest that the segment of the
oxidative TCA cycle culminating in succinate is necessary to
transmit reducing equivalents to NNT for the reductive pathway
(Figure 6I).
It is clear from the data that the cells studied here demonstrate
persistent oxidative metabolism despite their mutations in
oxidative enzymes and their citrate pools largely bearing the
labeling hallmarks of reductive metabolism. First, isotope label-
ing studies with [U-13C]glutamine revealed flow of carbon from
glutamine to succinate in a pattern identical to the conventionalCTCA cycle. Second, silencing SUCLG1 reduced the abundance
of succinate, which would not be expected in the absence of
oxidative succinate formation. Third, silencing OGDH sup-
pressed the formation of succinate and increased the NAD+/
NADH ratio. A recent study used computational flux modeling
to provide evidence that oxidative TCA cycle metabolism occurs
in the context of either hypoxia or cytBmutation and that oxida-
tion of acetyl-CoA produces a fraction of cellular succinate and
may account for the net direction of IDH (Fan et al., 2013).
Here, we used specific molecular approaches to demonstrate
that much of the succinate pool is derived from oxidation of
glutamine rather than acetyl-CoA and that interrupting this
pathway elicits changes in both the cellular redox state and in
the pathways available to produce citrate. Specifically, AKG de-
hydrogenase, which is required to produce succinate through
oxidative metabolism, is required for maximal activity of the
reductive pathway. Thus, the persistent oxidative metabolismell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authors 1685
Figure 6. AKG Dehydrogenase and NNT
Contribute to NAD+/NADH Ratio
(A) Two-photon fluorescence imaging of NADH in
143Bwt and 143Bcytb. Red indicates areas of
increased NADH abundance. Scale bar, 22 mm.
(B) NAD+/NADH ratio in 143Bwt and 143Bcytb
cells. Data are the average and SD of three to four
independent cultures. **p < 0.005 (Student’s t test).
(C) NAD+/NADH ratio in 143Bcytb following tran-
sient transfection with siRNAs against Luciferase
(siLUC) or OGDH (siOGDH). Data are the average
and SD of three to four independent experiments.
**p < 0.005 (Student’s t test).
(D) NAD+/NADH ratio in 143Bcytb following
transfection with siLUC or an siRNA pool
directed against niconatinomide nucleotide trans-
hydrogenase (siNNT). Data are the average and SD
of three to four biological replicates. *p < 0.05
(Student’s t test).
(E) Abundance of m + 5-labeled citrate in 143Bcytb
cells transfected with siLUC or siNNT and cultured
with [U-13C]glutamine. Abundance of labeled cit-
rate was calculated by multiplying the relative
abundance of total citrate by the fractional contri-
bution of the m + 5 isotopomer. Data are the
average and SD of three independent cultures.
**p < 0.005 (Student’s t test).
(F) NADP+/NADPH ratio in 143Bcytb cells following
transient transfection with siLUC or siOGDH. Data
are the average and SD of three independent cul-
tures. *p < 0.05 (Student’s t test).
(G) NADP+/NADPH ratio in 143Bcytb cells following
transient transfection with siLUC or siNNT. Data
are the average and SD of three independent cul-
tures. *p < 0.05 (Student’s t test).
(H) NADP+/NADPH ratio in 143Bcytb cells following
transient transfection with siLUC or siIDH2. Data
are the average and SD of three independent cul-
tures. Inset is a western blot depicting abundance
of IDH2 protein in both conditions. *p < 0.05
(Student’s t test).
(I) Model for induction of reductive carboxylation in
143Bcytb cells. Flux through AKG dehydrogenase
generates succinate and NADH, which is dissi-
pated by NNT to generate NADPH during reductive
carboxylation.of glutamine is required for both redox homeostasis and for
maintenance of TCA cycle metabolite pools in cells harboring
mitochondrial defects.
An induction of pyruvate carboxylation was also observed in
cells lacking cytb or FH. PC contributes to the TCA cycle,
although other than requiring acetyl-CoA as an activator, it1686 Cell Reports 7, 1679–1690, June 12, 2014 ª2014 The Authorsdoes not require concomitant oxidative
metabolism to function. Pyruvate carbox-
ylation produces OAA without the need
for glutamine metabolism or reductive
carboxylation, and thus its induction in
the cells observed here may signify a
role as a complementary source of TCA
cycle metabolites in addition to these
other pathways. In most glutamine-dependent cancer cells studied to date, pyruvate carboxylase
is dispensable (Cheng et al., 2011), although it seems to be
active in several types of tumors in vivo (Marin-Valencia et al.,
2012; Fan et al., 2009). Although PC-dependent contribution of
carbon to the TCA cycle was induced by mutation of cytb or
FH, it accounted for only a minority of TCA cycle metabolites,
and silencing PC increased the fractional contribution from
glutamine. In other cases of severe mitochondrial dysfunction,
PC or alternative pathways to citrate formation may play a
more prominent role than they do in the cell lines studied here.
For example, although human FH-deficient renal carcinoma cells
show evidence of reductive carboxylation, mouse embryonic
fibroblasts (MEFs) homozygous null for FH do not appear to
use this pathway (Adam et al., 2013). These cells have been
demonstrated to covalently modify a number of metabolic
enzymes through the nonenzymatic addition of fumarate to
cysteine residues, creating an S-(2-succino) cysteine group in
a process termed succination (Ternette et al., 2013). The mito-
chondrial isoform of aconitase is inhibited by succination in
FH-deficient MEFs, and this inhibition may prevent isocitrate
produced through mitochondrial reductive carboxylation from
being converted to citrate.
Succinate accumulation was observed in cells with cytb or FH
mutations. However, this accumulation was dispensable for
reductive carboxylation, because silencing SUCLG1 expression
had no bearing on the pathway as long as AKG dehydrogenase
was active. Furthermore, succinate accumulation was not a uni-
versal finding of cells using reductive carboxylation. Rather, high
succinate levels were observed in cells with distal defects in
the ETC (complex III: antimycin, cytb mutation; complex IV:
hypoxia), but not defects in complex I (rotenone, metformin,
NDUFA1 mutation). These differences reflect the known sup-
pression of SDH activity when downstream components of the
ETC are impaired and the various mechanisms by which succi-
nate may be formed through either oxidative or reductive meta-
bolism. Succinate has long been known as an evolutionarily
conserved anaerobic end product of amino acid metabolism
during prolonged hypoxia, including in diving mammals (Ho-
chachka and Storey, 1975; Hochachka et al., 1975). The terminal
step in this pathway is the conversion of fumarate to succinate
using the NADH-dependent ‘‘fumarate reductase’’ system,
essentially a reversal of succinate dehydrogenase/ETC complex
II (Weinberg et al., 2000; Tomitsuka et al., 2010). However, this
process requires reducing equivalents to be passed from
NADH to complex I, then to coenzyme Q, and eventually to com-
plex II to drive the reduction of fumarate to succinate. Hence,
producing succinate through reductive glutamine metabolism
would require functional complex I. Interestingly, the fumarate
reductase system has generally been considered as a mecha-
nism to maintain a proton gradient under conditions of defective
ETC activity. Our data suggest that the system is part of a more
extensive reorganization of the TCA cycle that also enables
reductive citrate formation.
In summary, we demonstrated that branched AKG meta-
bolism is required to sustain levels of reductive carboxylation
observed in cells with mitochondrial defects. The organization
of this branched pathway suggests that it serves as a relay sys-
tem to maintain the redox requirements for reductive carboxyla-
tion, with the oxidative arm producing reducing equivalents at
the level of AKG dehydrogenase and NNT linking this activity
to the production of NADPH to be used in the reductive carbox-
ylation reaction. Hence, impairment of the oxidative arm pre-
vents maximal engagement of reductive carboxylation. As both
NNT and AKG dehydrogenase are mitochondrial enzymes, theCwork emphasizes the flexibility of metabolic systems in the mito-
chondria to fulfill requirements for redox balance and precursor
production even when the canonical oxidative function of the
mitochondria is impaired.
EXPERIMENTAL PROCEDURES
Cell Lines, Culture, and Reagents
143Bwt, 143Bcytb, CCL16-B2, and CCL16-NDI1 cells were cultured with
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with penicillin/
streptomycin, 10% fetal bovine serum (FBS), L-glutamine (6 mM), uridine
(100 mg/ml), and sodium-pyruvate (1 mM). To generate vector-controlled
UOK262 cells (UOK262EV), PCDNA3.1 empty vector plasmid was transfected
with Fugene (Promega) to UOK262 cells. To isolate stable integration of the
plasmid, cells were continuously grown in G418 (300 mg/ml; Invitrogen).
Both cell lines were then cultured with 143B media supplemented with G418.
Metabolomics
Subconfluent culture dishes were incubated for 2 hr in DMEM that contained
15 mM glucose and 2 mM glutamine supplemented with 10% dialyzed FBS.
Following this, cells were washed twice with ice-cold saline and then overlaid
with 500 ml of cold methanol/water (50/50, v/v). Cells were transferred to an
Eppendorf tube and subjected to three freeze-thaw cycles. After rigorous vor-
texing, the debris was pelleted by centrifugation at 16,000 3 g and 4C for
15 min. Pellets were used for protein quantitation (BCA Protein Assay, Thermo
Scientific). The supernatant was transferred to a new tube and evaporated
to dryness using a SpeedVac concentrator (Thermo Savant). Metabolites
were reconstituted in 100 ml of 0.03% formic acid in analytical-grade water,
vortex-mixed, and centrifuged to remove debris. Thereafter, the supernatant
was transferred to a high-performance liquid chromatography (HPLC) vial for
the metabolomics study.
Targeted metabolite profiling was performed using a liquid chromatog-
raphy-tandem mass spectrometry (LC-MS/MS) approach. Separation was
achieved on a Phenomenex Synergi Polar-RP HPLC column (150 3 2 mm,
4 mm, 80 A˚) using a Nexera Ultra High Performance Liquid Chromatograph
(UHPLC) system (Shimadzu Corporation, Kyoto, Japan). The mobile phases
employed were 0.03% formic acid in water (A) and 0.03% formic acid in aceto-
nitrile (B). The gradient program was as follows: 0–3 min, 100% A; 3–15 min,
100%–0% A; 15–21 min, 0% A; 21–21.1 min, 0%–100% A; 21.1–30 min,
100% A. The column was maintained at 35C and the samples kept in the
autosampler at 4C. The flow rate was 0.5 ml/min, and injection volume was
10 ml. The mass spectrometer was an AB QTRAP 5500 (Applied Biosystems
SCIEX) with electrospray ionization (ESI) source in multiple reactionmonitoring
(MRM) mode. Sample analysis was performed in positive/negative switching
mode. Declustering potential (DP) and collision energy (CE) were optimized
for each metabolite by direct infusion of reference standards using a syringe
pump prior to sample analysis. The MRM MS/MS detector conditions
were set as follows: curtain gas 30 psi; ion spray voltages, 5,000 V (positive)
and 1,500 V (negative); temperature, 650C; ion source gas 1, 50 psi; ion
source gas 2, 50 psi; interface heater on; entrance potential, 10 V. In total,
173 water-soluble endogenous metabolites were targeted, with 92 metabo-
lites confidently detected above the baseline set by cell-free samples. The
MRM transitions (m/z), DPs (V), and CEs (V) of the detected metabolites are
listed in Table S1. Dwell time for each transition was set at 3 ms. Cell samples
were analyzed in a randomized order, and MRM data were acquired using
Analyst 1.6.1 software (Applied Biosystems SCIEX).
Chromatogram review and peak area integration were performed using
MultiQuant software version 2.1 (Applied Biosystems SCIEX). Although the
numbers of cells were very similar and each sample was processed identically
and randomly, the peak area for each detected metabolite was normalized
against the protein content of that sample to correct any variations introduced
from sample handling through instrument analysis. The normalized area values
were used as variables for the multivariate and univariate statistical data
analysis. The chromatographically coeluted metabolites with shared MRM
transitions were shown in a grouped format, i.e., alanine/sarcosine. All multi-
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SIMCA-P (version 13.0.1; Umetrics). The preprocessed data sets were
mean-centered and unit-variance scaled, and then evaluated by principal
component analysis to visualize the clustering trend as well as to detect and
exclude outlier data sets. The hierarchical clustering of metabolites in different
cell lines was analyzed using the R statistical package. Univariate statistical
differences of the metabolites between two groups were analyzed using
Student’s t test.
Quantitation of Citrate, a-Ketoglutarate, and Succinate
For the quantitation of citrate, a-ketoglutarate, and succinate, a 50 ml aliquot of
an internal standard (IS) mixture containing [13C6]-citrate (1 mM), [
13C4]-a-keto-
glutarate (10 mM), and [13C2]-succinate (1 mM) prepared in analytical-grade
water was added to 50 ml of the scraped cells. After adding 500 ml of precooled
methanol/water (50/50, v/v), the analyte/IS mix was extracted and prepared
using the same procedures as described above. To construct a calibration
curve for absolute quantitation, working solutions containing all the three ana-
lytes were prepared in 13 PBS at concentrations of 0.2, 0.5, 1, 2, 5, 10, 20, 50,
and 100 mM and then spiked with 50 ml of the same IS mixture. Thereafter, the
standard samples were processed as described under ‘‘Metabolomics.’’ For
LC-MS/MS analysis, only the MRM transitions of the three analytes and their
ISs were monitored, which were 191 > 111 for citrate, 197 > 116 for [13C6]-
citrate, 145 > 57.1 for a-ketoglutarate, 149 > 60 for [13C4]-a-ketoglutarate,
117 > 73.2 for succinate, and 119 > 74.2 for [13C2]-succinate, respectively.
Dwell time for each transition was set at 30 ms.
Chromatogram review, peak area integration, and concentration calculation
of each metabolites was performed using MultiQuant software version 2.1
(Applied Biosystems SCIEX). The concentration (micromoles per microliter)
of each detected metabolite was normalized against the protein amount of
that sample to achieve the final units of micromoles per milligram of protein.
The normalized concentrations were compared between different cell lines
by using Student’s t test. Differences with p < 0.05 were considered as statis-
tically significant.
Quantitation of (L)-2HG and (D)-2HG
Measurement of D-2HG and L-2HG was performed as described previously
(Rakheja et al., 2011a, 2011b). Briefly, the metabolite extracts were derivatiza-
tion with (+)-Di-O-acetyl-L-tartaric anhydride and injected for chromato-
graphic separation on an Agilent Hypersil ODS 4.0 3 250 mm, 5 mm column
followed by detection and measurement using an API 3000 triple-quadrupole
mass spectrometer equipped with an ESI source (Applied Biosystems). MRM
transitions were monitored at 363.2 > 147.2 for both L-2HG and D-2HG.
Isotope-Labeling Experiments
Isotope-labeling experiments were essentially preformed as described previ-
ously (Mullen et al., 2012). Briefly, DMEM with 10% dialyzed FBS was supple-
mented with isotopically labeled glucose or glutamine at a concentration of
15 mM and 2 mM, respectively. Unless specified, cells were incubated for
exactly 2 hr. After this, dishes were washed twice with cold saline and metab-
olites were extracted in 50% methanol followed by three freeze-thaw cycles.
Extracts were centrifuged and supernatant was dried. Metabolites were deri-
vitized with Trisil (Thermo Scientific) and analyzed on an Agilent 6970 gas chro-
matograph networked to an Agilent 5973 mass-selective detector. A detailed
list of all masses monitored was provided previously (Cheng et al., 2011;
Mullen et al., 2012).
RNAi
Transient gene-silencing experiments were performed using commercial
siRNA pools as described previously (Mullen et al., 2012). Briefly, siRNA oligos
targeting SUCLG1, OGDH, or NNT (siGenome, Thermo Scientific) were trans-
fected into 143B cells with DharmaFECT transfection reagent (Thermo Scien-
tific); oligos targeting luciferase were used as a negative control (siGenome,
Thermo Scientific). All experiments took place 72 hr later and were carried
out as described above. For stable gene silencing, lentiviral-mediated shRNAs
targeting PC or OGDH from the Mission shRNA pLKO.1-puro library (Sigma)
were used to infect 143Bcytb cells according to supplied protocol. 143B cells
were infected with an individual shRNA hairpin and stable integrants were
selected with Puromycin (Invitrogen).1688 Cell Reports 7, 1679–1690, June 12, 2014 ª2014 The AuthorsTo monitor protein abundance, cells were lysed in RIPA buffer and protein
separated on NuPAGE Novex 4%–12% Bis-Tris gel (Invitrogen). Protein was
transferred to Immobilon transfer membranes (Millipore). Protein was detected
using commercially available antibodies against SUCLG1 (Cell Signaling Tech-
nology), OGDH (Sigma), or PC (Santa Cruz Biotechnology). NNT knockdown
was quantified using quantitative PCR (qPCR). Briefly, RNA was extracted in
TRIzol (Invitrogen) and isolated according to manufacturer’s protocol. cDNA
was generated using iScript synthesis kit (Bio-Rad), and transcript abundance
was measured on a Thermo qPCR instrument.Colony Formation in Soft Agar
Cells (10 3 103 cells per well) were suspended in growth medium containing
0.3% agarose and plated in six-well dishes onto a base layer composed of
growth medium containing 0.6% agarose. The growth medium was replen-
ished every 4 days, and after 14 days, colonies greater than 100 mm in size
were counted. Each condition was performed in triplicate wells, and the entire
experiment was repeated three times.
NAD+/NADH and NADP+/NADPH Measurements
The NAD+/NADH ratio was measured using a commercially available kit
(BioVision, K337-100). Extraction andmeasurements were performed accord-
ing to manufacturer’s protocol. Briefly, cells were incubated 2 hr with DMEM
supplemented with 10% dialyzed FBS and unlabeled glucose and glutamine
at a concentration of 15 mM and 2 mM, respectively. After this, cells were
washed twice with saline and fresh saline was added so that cells could be
scraped off the dishes and pelleted. Next, NAD+ and NADH were extracted
in the supplied extraction buffer. Samples were subjected to two freeze-
thaw cycles and centrifuged. Aliquots of each sample were heated at 60C
for 30 min to decompose NAD+. Following this, samples were loaded to 96-
well plates and for absorbance measurement at OD450. The NADP
+/NADPH
ratio was measured using a commercially available kit (Abcam, ab65349).
Cells were washed with cold saline, then fresh saline was added so that the
cells could be scraped from the dishes and pelleted. Next, NADP+ and NADPH
were extracted in the supplied extraction buffer. Samples were subjected to
two freeze-thaw cycles and centrifuged. Aliquots of each sample were heated
at 60C for 30 min to decompose NADP+. Samples were then transferred to
96-well plates for absorbance measurement at OD450.Two-Photon Fluorescence of NADH
NADH was imaged using two-photon fluorescence microcopy. Cells were
seeded to 35 mm glass-bottom petri dishes. Before imaging, media was re-
placed with DMEM lacking phenol red. Cells were imaged on a Zeiss LSM
510 META with Chameleon XR NIR laser. NADH fluorescence was imaged
after excitation at 775 nm. To better demonstrate the changes in NADH inten-
sity, a rainbow color table was applied to the images using Image J (ImageJ,
National Institutes of Health; http://rsb.info.nih.gov/ij/).Statistical Methods
Unless otherwise indicated, data were analyzed in either Microsoft Excel
or GraphPad Prism. Statistical significance was established using Student’s
t test.SUPPLEMENTAL INFORMATION
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